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A B S T R A CT  
The emergence of SARS-CoV-2 has resulted in > 36,361,054 infections and > 1,056,186 deaths 
worldwide. Using publicly available genome sequences of patient samples from different 
geographical regions, a study has been conducted to co-relate mutational frequency with disease 
transmission and fatality rate. Seven hundred genome sequences were randomly chosen from 
different countries. The regions of the genome encoding structural proteins Spike (S), Nucleocapsid 
(N), envelop (E) and Membrane (M) proteins and ORF8 were studied here. Through Insilco 
approach, this study showed that several evolutionary conserved amino acid residues underwent 
mutations. Some of these mutations are common in multiple geographies. Quite a few region-
specific mutations are also identified. This study highlights that mutational rate is proportional to 
disease transmission and inversely proportional to disease fatality. The changes in the conserved 
residues have significant implication on the stability of the proteins and subsequent interaction, 
which are essential for virus propagation. This provides a better understanding of the genetic 
variation in SARS-CoV-2 across the countries and its association with reducing disease fatality.  
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1 Introduction 
The COVID-19 pandemic caused by a novel 2019 SARS coronavirus, known as SARS-CoV-2, is 
rapidly spreading worldwide after one month of the initially identified case on December 2019, in 
Wuhan city, China [1]. The genome sequence study has revealed that SARSCoV-2 is a member of the 
genus Beta-coronavirus and belongs to the subgenus Sarbecovirus that includes SARS-CoV while 
MERS-CoV belongs to a separate subgenus, Merbecovirus [2, 3]. Epidemiological data suggests that 
SARS-CoV-2 had spread widely from the city of Wuhan in China [4] after its zoonotic transmission 
originating from bats via the Malayan pangolins [5]. It has spread over 200 countries and infected 
millions of people worldwide. As the number of the positive cases increasing drastically, the World 
Health Organization (WHO) raised the importance of understanding genetic changes through mutation 
that could have occurred in the SARS-CoV-2. The SARS-CoV-2 genome is composed of approximately 
30,000 nucleotides [5]. The genome includes a variable number (from 6 to 11) of open reading frames 
(ORFs) [6]. The first ORF (ORF1ab) representing approximately 67% of the entire genome encodes 16 
non-structural proteins (nsps), while the remaining ORFs encode accessory proteins including ORF8 
and structural proteins. The four major structural proteins are the spike surface glycoprotein (S), small 
envelope protein (E), membrane protein (M), and nucleocapsid (N) protein [6].  
Searching for mutations and their evolutionary conservation while the virus continues to spread, can 
offer opportunities for a better understanding of virus evolution, biopathology, and transmission. 
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Having this motivation, considering Wuhan based genome NC_045512.2 as reference, this study 
attempted to understand worldwide common hotspots, varying mutational frequency from region to 
region and its association for reducing disease fatality. 
2 Methods 
In the present report we randomly chosen ~ 700 genome sequences (sourced from Global Initiative on 
Sharing All Influenza, GISAID, https://www.gisaid.org/ and NCBI) worldwide. The study is based on 
sequence alignments and used NCBI BLAST, and CLUSTAL OMEGA. Wuhan isolate, SARS-CoV-2 
sequence NC_045512.2 (length 29903 nt) was used as a reference sequence and for sequence 
comparisons.  
Mutational rate has been calculated by counting total number of missense mutations in all structural 
proteins (Spike, Nucleocapsid, Envelope and Membrane proteins) and ORF8 (considered in this study) 
in each genome followed by dividing the total number of genome sequences undergone mutation. The 
regions in which sufficient genome sequences (minimum 10 and maximum 60 genome sequences) are 
not available during this study has been excluded. 
Fatality rate of each country was measured using cumulative death (https://covid19.who.int/) divided 
by total number of affected cases and then multiplied by hundred. 
3 Results 
All the different types of missense mutations in S, N, E and ORF8 proteins have been recorded and 
placed in tables (1, 2, 3, 4). S protein contains maximum number of mutational hotspots (Table 1). All 
the countries studied here, have common D614G mutation for S protein. India has maximum number 
of different types of substitution in S protein. Similarly, N protein has few mutations which are common 
in many countries (table 2). ORF8 (table 3) and E protein (table 4) have very few mutations whereas M 
protein doesn’t have any mutation for the genome sequences studied here. 
 
L5F substitution in S protein was found in some genome sequences from the patient samples of 
Bangladesh, India, Italy (very few), Philippines and USA. This (L5F mutation) is mostly coupled with 
D614G substitution. In addition, L54F substitution was found in few sequences of patient samples from 
India which is coupled with D614G mutation. The receptor-binding domain or RBD of the S protein of 
SARS-CoV-2 lies between amino acids 330 and 583. Maximum number of mutations were found in N 
terminal domain followed by RBD and C terminal domain (Table 1). 
   S194L, S202N, R203G, G204R mutations are abundantly found in N (nucleocapsid) protein. These 
mutations are found in sequences from multiple countries. Again, like S protein, India has maximum 
number of different types of substitution in N protein (table 2). T205I mutation is only noted in all N 
protein sequences from Iraq. P67S or S235F are found in many sequences (N protein) from USA and 
these are not coupled with any of the other mutations such as S194L, S202N, R203G and G204R. 
 
   For ORF8, very few mutational hotspots were found in the sequences studied here. USA has 
maximum number of substitutions in ORF8 (table 3). L84S mutation is common among the sequences 
of patient samples from India and USA. 
This study reports very few mutations in E protein (table 4). It did not find any common mutational 
hotspot in sequences from multiple countries. 
  Next, mutation rate was calculated and plotted with respect to different countries (figure 1). It shows 
that Bangladesh, India and Philippines have the highest mutational frequency whereas Australia, Italy, 
Egypt have least.  
 Then fatality rate was calculated using WHO cumulative death (https://covid19.who.int/) and plotted 
against mutational rate. This study reports that they are inversely related (figure 2). 
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Figure 1: Mutational rate has been plotted with respect to country. It has been calculated by counting number of 
missense mutations in all structural proteins and ORF8 in each followed by dividing the total number of genome 
sequences undergone mutation. We excluded regions in which sufficient genome sequences (minimum 10 and 
maximum 60 genome sequences) are not available during this study 
 
Figure 2: Mutational and fatality rates have been plotted. Fatality rate has been calculated using cumulative 
death (https://covid19.who.int/) divided by total number of affected cases and then multiplied by hundred 
4 Discussion 
   Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is being intensively studied, 
particularly its evolution, in the increasingly available sequences with classical phylogenetic tree 
representation. This study reports certain amino acid variations in structural proteins and ORF8 and its 
possible implication for altering structure, function, infectivity and fatality. 
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Table 1: The different types of missense mutations in S (Spike) protein for different countries (vertically) are 
placed in tabular form. Single letter amino acid code has been used and placed horizontally in table; + is used 
for presence and - is used for absence of respective mutation 
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Country                                    
Australia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Bangladesh  +  -  -  -  +  +  -  +  -  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  +  - 
Brazil  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -   -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Chile  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Czech 
Republic  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Denmark  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  +  -  -  -  -  -  -  -  -  - 
Egypt  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
France  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Germany  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Greece  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  +  -  -  - 
India  +  -  -  +  -  -  +  -  +  +  -  +  +  -  -  -  -  -  -  +  -  -  +  +  +  -  +  -  +  -  -  +  -  - 
Iran  -  -  -  -  -  -  -  -  -  -  +  -  -  -  +  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Iraq  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  +  -  -  -  -  -  -  -  -  - 
Italy  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Jamaica  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Japan  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Jordan  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Mexico  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Morocco  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Netherland  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  +  -  -  -  +  -  -  -  -  -  -  -  -  - 
Philippines  +  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Poland  -  -  -  -  -  -  -  -  -  -  -  -  -  +   -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Puerto Rico  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Russia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Spain  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Sri Lanka  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
Taiwan  -  -  -  -  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  +  -  -  -  -  -  - 
Tunesia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
UK  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
USA  +  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  -  + 
 
 
 Coronavirus entry into host cells is mediated by the transmembrane spike (S) protein that forms 
homotrimers protruding from the viral surface [7]. S protein comprises two functional subunits, 
responsible for binding to the host cell receptor (S1 subunit) and fusion of the viral and cellular 
membranes (S2 subunit). For many Coronaviruses, S is cleaved at the boundary between the S1 and S2 
subunits, known as furin cleavage site and remain non-covalently bound in the prefusion conformation. 
This region is reported to be the most potent and indispensable for viral attachment and entry into host 
system [8]. This study reports that amino acid at position 614 (a residue close to furin cleavage site) 
underwent mutation (D614G) which is common across all geographies. Earlier study reported that 
amino acid at position 614 occurs at an internal protein interface of the viral spike, and the presence of 
G at this position destabilises a specific conformation [9]. There are several other miss-sense mutations 
in S protein (table 1). All these mutations could be classified as stabilizing and destabilizing based on 
the free-energy changes. L5F mutation in sequences from Bangladesh, India, Italy (very few), 
Philippines and USA patient samples and L54F mutation in sequences from India, are mostly coupled 
with D614G substitution. Both of the amino acids (leucine and phenylalanine) are non-polar, but 
phenylalanine has a benzoic ring in the side chain which may stiffen the secondary structure by means 
of aromatic-aromatic, hydrophobic or stacking interactions. Earlier report in Non- Structural Protein 6 
(NSP6) by amino acid change stability (ACS) analysis showed that this (leucine to phenylalanine) leads 
to a lower stability of the protein structure [10]. There are multiple residues in receptor binding domain 
(RBD) which play important role in binding to ACE2 (angiotensin converting enzyme 2) receptor [11]. 
This study reports multiple point mutations in neighbouring amino acids of ACE2 binding residues. All 
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these potentially play important role for increasing person to person transmission by altering the affinity 
to ACE2, stability of protein and interaction with neighbouring molecules. 
 
Table 2: The different types of missense mutations in N (nucleocapsid) protein for different countries 
(vertically) are placed in tabular form. Single letter amino acid code has been used and placed horizontally in 
table; + is used for presence and - is used for absence of respective mutation 
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Bangladesh  -  -  -  -  -  -  -  -  -  -  -  +   -  -  -  -  +  +  -  -  +  -  -  -  - 
Brazil  -  -  -  -  -  -   -  -  -  -  -   -  -  -  -  +  +  -  -  -  -  -  -  - 
Chile  -  -  -  -  -  -   -  -  -  -  -   -  -  +  -  +  +  -  -  -  -  -  -  - 
Czech Republic  -  -  -  -  -  -   -  -  -  -  -   -  -  -  -  +  +  -  -  -  -  -  -  - 
Denmark  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Germany  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Greece  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
India  +  -  +  +  +  -  -  -  +  +   -  -   +  -  +  +  +  -  -  -  +  -  +  - 
Iran  -  -  -  -  -  -  -  -  -  -  +  -  -  +  +   -  -  -  -  -  -  -  -  -  - 
Iraq  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  - 
Israel  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Italy  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Jamaica  -  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - 
Japan  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Mexico  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  -  -  - 
Morocco  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  - 
Philippines  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Poland  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Puerto Rico  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Russia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Russia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Russia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Russia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Sri Lanka  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Taiwan  -  -  +  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
Tunesia  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  -  -  -  -  -  -  -  -  - 
UK  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  +  +  -  -  -  -  -  -  - 
USA  -  -  -  -  -  +  +  -  -  -  -  -  +  -  -  -  -  +  +  -  +  -  -  -  -  + 
 
The nucleocapsid (N) protein is an important structural protein for the coronaviruses. It is highly 
abundant in the viruses. Its function involves, entering into the host cell, binding to the RNA, and 
forming the ribonucleoprotein core. It consists of RNA binding domain (RBD; residues 44-180) in the 
N-terminal region (N) of the protein, linker peptide (residues 181-246), the dimerization domain (DD; 
residues 247-364) in the C-terminal region [12]. Three disordered regions were reported on 1) N 
terminal (residues 1-43), 2) linker peptide, and 3) C terminal end (residues 365-419) [12]. This study 
reports multiple point mutations in linker region (S194L, S202N, R203K and G204R) and these are 
found to be common for many countries (Table 2).  Earlier report pointed out that these positions are 
evolutionary conserved [13]. It was also reported that multiple disordered regions facilitate the N 
protein to transiently bind to different partners and maintain a correct conformation [12]. The hotspots 
reported here, surround with GSK3 phosphorylation ‘SRGTS’ (amino acid position 202-206) and CDK 
phosphorylation ‘SPAR’ (amino acid position 206-209) motifs [14]. Most possibly the substitutions 
alter the binding affinity to attain the stable conformation and simultaneously contribute towards 
enhancing transmission rate.  
 
This study reports very few substitutions in ORF8 (table 3). L84S was noted in sequences from USA 
and India. I39V was found in ORF8 sequences from Bangladesh. Earlier study showed that ORF8 along 
with N and ORF3b are potent interferon antagonist, in the early stages of SARS-CoV-2 infection [15]. 
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It hinders the host's antiviral response and then benefit virus replication by delaying the release of IFNs 
[15]. For L84S, Leu is non-polar hydrophobic whereas Ser is polar amino acid. Ser residue undergoes 
phosphorylation and possibly play an important role for reducing anti-interferon activity and hence the 
disease severity. 
 
Table 3: The different types of missense mutations in ORF8 protein for different countries are placed in tabular 
form. Single letter amino acid code has been used; + is used for presence and - is used for absence of respective 
mutation 
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Bangladesh  -  -  -  +  -  -  - 
India  -  +  -  -  -  -  + 
USA  +  -  +  -  +  +  + 
 
The envelope (E) protein is a small, integral membrane protein involved in several aspects of the virus’ 
life cycle, such as assembly, budding, envelope formation, and pathogenesis. The SARS-CoV E protein 
consists of three domains, i.e. the amino (N)-terminal domain (residues ~1-8), the transmembrane 
domain (TMD, residues 9 -38)), and the carboxy (C)-terminal domain (residues 39-75) [16]. We found 
very few genetic variation (L21F, I33T, L49M, V62F) in E protein and none of these substitutions are 
common worldwide (table 4). L21F potentially interfere the oligomerisation of SARS-CoV2 as it was 
shown earlier that V25F hampers the oligomerisation of SARS-CoV E [16]. V62F mutation in C- 
terminal domain can potentially interfere the interaction with target proteins, thereby altering the host-
cell processes required for viral infection [12]. 
This analysis does not find any substitution in Membrane (M) protein in the genome sequences of ~700 
patient samples of different geographical regions. This implies that M protein is comparably stable and 
supports our earlier study [13]. 
 
Table 4: The different types of missense mutations in E (envelope) protein for different countries are placed in 
tabular form. Single letter amino acid code has been used; + is used for presence and - is used for absence of 
respective mutation 
 
Mutation → 
V
5
A
 
L2
1
F 
I3
3
T 
L4
9
M
 
V
6
2
F 
Country   -  -  -  -  - 
Brazil  +  -  -  -  - 
Philippines  -  +  -  -  - 
Greece  -  -  -  +  - 
India  -  -  -  -  + 
Iran  -  -  +  -  - 
 
We noticed D614G for S and S194L, S202N, R203K, G204R for N proteins are common mutations for 
all most all countries except China (at least the genome sequences studied here). While looking into the 
total affected cases and fatality rate from WHO data (https://covid19.who.int/), China shows 
comparatively less transmission rate but more fatality.  
 
To understand the possible implication of these mutations, first we plotted mutational frequency (rate) 
with respect to different countries (figure 1). It shows that Bangladesh, India and Philippines have the 
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highest mutational frequency. Then we tried to relate mutational frequency with fatality rate. Very 
interestingly, the result shows that Bangladesh, India and Philippines have less fatality whereas Italy, 
Mexico, France have less mutation but more fatality. In other words, the fatality rate is decreasing with 
increasing mutation rate or vice versa (figure 2). This finding is consistent with earlier studies on NSP6, 
S protein and RNA‐dependent RNA polymerase (RdRP) [17, 18].  
5  Conclusion 
This study reports several missense mutations for around seven hundred SARS-CoV2 genome 
sequences studied here of patients from diverse geographical-locations. Within a very short time frame, 
the virus evolved rapidly. Quite a few common mutations across geographies in S protein, N protein, 
and also in ORF8 indicate that these variations were mostly carried by the patients with travel history 
and then transmitted to neighbouring or family members. The potential implication of these may link 
to enhancing the infectivity, easy person to person transmission. There are many variations those were 
evolved within the country as we found quite a few country specific mutations. Although the clinical 
significance of the observed mutations is not yet available, our findings lay the groundwork to 
understand the impact of SARS-CoV2 mutations on disease severity. This study also warrants the 
importance of sequencing the whole genome of SARS-CoV-2 after several passages and key mutations 
should be used for the effective drug designing and treatment options. All together our findings make 
us optimistic that the disease severity will diminish as we move along with time and more genomic 
variations. 
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